Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans

Molecular Nutrition and Food Research

Volumn 51, Issue 1, 2007, Pages 61-99

  Pfohl Leszkowicz, Annie ^a,c   Manderville, Richard A ^b  

^a Ecole Nationale Superieure d'Architecture de Toulouse   (France)

^b UNIVERSITY OF GUELPH   (Canada)

^c LABORATOIRE DE GÉNIE CHIMIQUE   (France)

Author keywords

Carcinogenicity; DNA adducts; Genotoxicity; Kidney tumours; Ochratoxin A

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT; MYCOTOXIN; OCHRATOXIN;

ANIMAL; BONE MARROW; CHEMICALLY INDUCED DISORDER; DNA ADDUCT; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; IMMUNE SYSTEM; KIDNEY; NEOPLASM; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; BONE MARROW; CARCINOGENS; DNA ADDUCTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; KIDNEY; MUTAGENS; MYCOTOXINS; NEOPLASMS; OCHRATOXINS; TISSUE DISTRIBUTION;

ANIMALIA; FUNGI; RATTUS; SUIDAE; SUS;

EID: 33846454704     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600137     Document Type: Review

References (504)

1. Tanchev, I., Evstatiev, Z. V., Dorosiev, G., Pencheva, Z. H., Zvetkov, G., Studies on nephritis in the region of Vratza, Savr. Med. 1956, 7, 14-29 (in Bulgarian).
2. Danilovic, V., Djurišic, M., Mokranjac, M., Stojimirovic, B. et al., Porodicna oboljenja bubrega u selu Šopic izvazvana hronicnom intoksikácijon olovorm, Srp. Arh Celok. Lek. 1957, 85, 1115-1125.
3. Danilovic, V., Djurišic, M., Mokranjac, M., Stojimirovic, B. et al., Chronic nephritis caused by poisoning with lead via the digestive tract (flour), Presse Méd 1957, 65, 2039-2040.
4. Fortza, N., Negoescu, M., Nefrita cronica azotemica endo-epidemica, Cercet Med. 1961, 1, 217-221.
5. World Health Organisation, Memoranda. The Endemic Nephropathy of South-Eastern Europe, WHO, Geneva 1965. pp. 431-448.
6. Fuchs, R., Peraica, M., Ochratoxin A in human kidney diseases, Food Addit. Contam. 2005, Suppl. 1, 53-57.
7. Vukelic, M., Sostaric, B., Belicza, M., Pathomorphology of Balkan endemic nephropathy, Food Chem. Toxicol. 1992, 30, 193-200.
8. Plestina, R., Stavljenic, A., Ceovic, R., Fuchs, R., Haematological features of the population of the area of Croatia, Yugoslavia, endemic for Balkan nephropathy, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozerasky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC, Lyon 1991, pp. 43-46.
9. Plestina, R., Some features of Balkan endemic nephropathy, Food Chem. Toxicol. 1992, 30, 177-181.
10. Stefanovic, V., Polenakovic, M. H., Balkan nephropathy, Am. J. Nephrol. 1991, 11, 1-11.
11. Chernozemsky, I. N., Stoyanov, I. S., Petkova-Bocharova, T. K., Nikolov, I. G. et al., Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district Bulgaria, Int. J. Cancer 1977, 19, 1-11.
12. Ceovic, S., Hrabar, A., Šaric, M., Epidemiology of Balkan endemic nephropathy, Food Chem. Toxicol. 1992, 30, 183-188.
13. Ceovic, S., Mitelic-Medev, M. Epidemiological features of Endemic Nephropathy in the focal area of Brodska Posovina, Croatia, in: Cvorišcec, D., Ceovic, S., Stavljenic-Rukavina, A. (Eds.), Endemic Nephropathy in Croatia, Academia Croatica Scientiarum Medicarum, Zagreb, Croatia 1996, pp. 7-21.
14. Gluhovschi, G., Margineanu, F., Trandafirescu, V., Schiller, A. et al., Balkan endemic nephropathy in Romania, Facta Univ. Ser. Med. Biol. 2002, 9, 15-25.
15. Dimitrov, T., Balkan endemic nephropathy in Bulgaria, Facta Univ. Ser. Med. Biol. 2002, 9, 7-14.
16. Dimitrov, T., Is the incidence of Balkan endemic nephropathy decreasing? Pathol. Biol. 2002, 50, 38-41.
17. Markovic, N., Ignjatovic, I., Cukuranovic, R., Petrovic, B. et al., Decreasing incidence of urothelial cancer in Balkan endemic nephropathy region in Serbia. A surgery based study from1969-1989, Pathol. Biol. (Paris) 2005, 53, 26-29.
18. Mileti-Medved, M., Domijan, A.-M., Peraica, M., Wien. Klin. Wochenschr. 2005, 117, 604-609.
19. Bordas, E., Bretter, E., Costin, L., Lenghel, I., Méd. Soc. Santé Publ. 1973, 21, 481-498.
20. Ceovic, S., Radonic, M., Hrabar, A., Radosevic, Z. et al., Endemic nephropathy in Brodska Posavina - in a twenty year period, in: Strahinjic, S., Stefanovic, V. (Eds.), Endemic (Balkan) Nephropathy (Proceedings of the 4th Symposium on Endemic Nephropathy), Institute of Nephrology, Nis, Yugoslavia 1979, pp. 223-277.
21. Ceovic, S., Hrabar, A., Radonic, M., An etiological approach to Balkan endemic nephropathy based on the investigation of two genetically different populations, Nephron 1985, 40, 175-179.
22. Markovic, B., Lebedev, S., Djordjevic, M., Arambasic, M., Endemic urinary tract cancer in Bulgaria, Yugoslavia and Romania: Etiology and pathogenesis, Méd. Biol. Environ. 1976, 1-2.
23. Markovic, B., Néphropathie des Balkans et carcinomes à cellules transitionnelles, J. Urol. (Paris) 1985, 91, 215-220.
24. Gluhovschi, G., Rosca, A., Margineanu, F., Hantavirus-specific IgG and IgM in Balkan endemic nephropathy (BEN) and chronic renal disease, Facta Univ. Ser. Med. Biol. 2002, 9, 76-78.
25. Radovanovic, Z., Balkan endemic nephropathy in Serbia: Current status and future research, Facta Univ. Ser. Med. Biol. 2002, 9, 26-30.
26. Šostaric, B., Vukelic, M., Characteristic of urinary tract tumours in the area of Balkan endemic nephropathy in Croatia, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 29-35.
27. Hall, P. W., Dammin, G. J., Griggs, H. H., Fajgolj, A. et al., Investigation of chronic endemic nephropathy in Yougoslavia: Renal pathology, Am. J. Med. 1965, 39, 210-217.
28. Hall, P. W., Dammin, G. J., Balkan nephropathy, Nephron 1978, 22, 281-300.
29. Petrovic, B., Kovic, B., Cukuranovic, R., Stefanovic, V., Malignant bladder tumors and Balkan endemic nephropathy: Possible common etiologic factor, Facta Univ. Ser. Med. Biol. 2002, 9, 108-113.
30. Toncheva, D., Dimitrov, T., Stojanova, S., Etiology of Balkan endemic nephropathy: A multifactorial disease? Eur. J. Epidemiol 1998, 14, 389-394.
31. Krasteva, M. E., Georgieva, E. I., Germline p53 single-base changes associated with Balkan endemic nephropathy, Biochem. Bipohys. Res. Commun. 2006, 342, 562-567.
32. Atanasova, S. Y., von Ahsen, N., Toncheva, D., Dimitrov, T. G. et al., Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN), Clin. Biochem. 2005, 38, 223-228.
33. Andonova, I. E., Sarueva, R. B., Horvath, A. D., Simeonov, V. A. et al., Balkan endemic nephropathy and genetic vaiants of glutathione S-transferases, J. Nephrol. 2004, 17, 390-398.
34. Nikolic, J., Djojic, M., Crnomarkovic, D., Marinkovic, J., Upper urothelial tumors and Balkan endemic nephropathy-dose responsible diseases, Facta Univ. Ser. Med. Biol. 2002, 9, 114-118.
35. Akhmeteli, M. A., Epidemiology of endemic nephropathy, in: Endemic Nephropathy, Proceedings of the Second International Symposium on Endemic Nephropathy 9-12 November 1972, Bulgarian Academy of Sciences, Sofia, Bulgaria 1972, pp. 19-23.
36. Linsell, C. A., Peers, F., The aflatoxins and human liver cancer, Cancer Res. 1972, 39, 125-129.
37. Krogh, P., Mycotoxic porcine nephropathy - a possible model for Balkan (endemic) nephropathy, in: Endemic Nephropathy, Proceedings of the Second International Symposium on Endemic Nephropathy 9-12 November 1972, Bulgarian Academy of Sciences, Sofia, Bulgaria 1972, pp. 266-277.
38. Speijers, G. J. A., van Egmond, H. P., Worldwide ochratoxin A levels in food and feeds, in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, London 1993, Vol. 231, pp. 85-100.
39. Krogh, P., Hald, B., Plestina, R., Ceovic, S., Balkan (endemic) nephropathy and food borne ochratoxin A: Preliminary results of a survey in foodstuff, Acta Pathol. Microbiol. Scand. B 1977, 85, 238-240.
40. Pavlovic, M., Plestina, R., Krogh, P., Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy, Acta Pathol. Microbiol. Scand. B 1979, 87, 243-246.
41. Radic, B., Fuchs, R., Peraica, M., Lucic, A., Ochratoxin A in human sera in the area with endemic nephropathy in Croatia, Toxicol. Lett. 1997, 91, 105-109.
42. Jurjevic, Z., Solfrizzo, M., Cvjetkovic, B., Avantoggiato, G., Visconti, A., Ochratoxin A and Fumonisin (B1 and B2) in maize from Balkan nephropathy endemic and non endemic areas of Croatia, Mycotoxin Res. 1999, 15, 67-80.
43. Puntaric, D., Bosnir, J., Smit, Z., Skes, I., Baklaic, Z., Ochratoxin A in corn and wheat: Geographical association with endemic nephropathy, Croatian Med. J. 2001, 42, 175-180.
44. Petkova-Bocharova, T., Castegnaro, M., Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria, Food Addit. Contam. 1985, 2, 267-270.
45. Petkova-Bocharova, T., Castegnaro, M., Michelon, J., Maru, V., Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon 1991, pp. 83-87.
46. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N., Castegnaro, M., Balkan endemic nephropathy and the associated urinary tract tumors: Review on etiological causes, potential role of mycotoxins, Food Addit. Contam. 2002, 19, 282-302.
47. Vrabcheva, T., Usleber, E., Dietrich, R., Martlbauer, E., Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy, J. Agric. Food Chem. 2000, 48, 2483-2488.
48. Abouzied, M. M., Horvath, A. D., Podlesny, P. M., Regina, N. P. et al., Ochratoxin A concentration in food and feed from a region with Balkan endemic nephropathy, Facta Univ. Ser. Med. Biol. 2002, 9, 129.
49. Czerwiecki, L., Czajkowska, D., Witkowska-Gwiazdowska, A., On ochratoxin A and fungal flora in Polish cereals from-conventional and ecological farms, Food Addit. Contam. 2002, 19, 470-477.
50. Jørgensen, K., Jacobsen, J. S., Occurence of ochratoxin A in Danish wheat and rye, 1992-1999, Food Addit. Contam. 2002, 19, 1184-1189.
51. Elmholt, S., Ecology of ochratoxin A producing Penicillium verrucosum, Occurence in field soil and grain with special attention to farming systme and on-farm frying practices, Biol. Agric. Hortic. 2003, 20, 311-337.
52. Vrabcheva, T., Petkova-Bocharova, T., Grosso, F., Nikolov, I. et al., Analysis of ochratoxin A in food consumed by inhabitants from an area with Balkan endemic nephropathy: A one month follow up study, J. Agric. Food Chem. 2004, 52, 2404-2410.
53. Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T. et al., Balkan endemic nephropathy: Role of ochratoxin A through biomarkers, Mol. Nutr. Food Res. 2006, 50, 519-529.
54. Pepeljnjak, S., Blazevic, N., Contamination with moulds and occurrence of ochratoxin A in smoked meat products from endemic nephropathy regions in Yugoslavia, in: Pfannhauser, W., Czedick-Eysenberg, P. B. (Eds.), Proceedings of the Vth IUPAC Symposium on Mycotoxins and Phycotoxins, 1-3 September, Vienna, Austrian Chemical Society, Vienna, Austria 1982, pp. 102-105.
55. World Health Organisation, Toxicological evaluation of certain food additives and contaminants, WHO Food Additives Series 1990, Vol. 26.
56. Breitholtz-Emanuelson, A., Olsen, M., Oskarson, A., Palminger, I., Hult, K., Ochratoxin A in cow's milk and in human milk with corresponding human sample blood, J. Assoc. Off. Anal. Chem. 1993, 76, 842-846.
57. Jørgensen, K., Survey of pork, poultry, coffee, bier and pulses for ochratoxin A. Food Addit. Contam. 1998, 5, 550-554.
58. Jørgensen, K., Occurrence of ochratoxin A in commodities and processed food-A review of EU occurrence data, Food Addit. Contam. 2005, Suppl. I, 26-30.
59. Curtui, V. G., Gareis, M., Usleber, E., Märtlbauer, E., Survey of Romanian slaughtered pigs for the occurence of mycotoxins ochratoxin A and B, and zearalenone, Food Addit. Contam. 2001, 18, 730-738.
60. Stoev, S. D., Kunev, I., Radic, B., Haematological, biochemical and toxicological investigations in spontaneous cases of mycotoxic nephropathy (ochratoxicosis) in pigs, Bulgarian J. Agric. Sci. 1997, 3, 507-516.
61. Stoev, S. D., Stoeva, J. K., Anguelov, G., Hald, B. et al., Haematological, biochemical and toxicological investigations in spontaneous cases with different frequency of porcine nephropathy in Bulgaria, J. Vet. Med. 1998, 45, 229-236.
62. Hult, K., Hökby, E., Hägglund, U., Gatenbeck, S. et al., Ochratoxin A in blood from slaughter pigs in Sweden, use in evaluation of toxin content of consumed feed, Appl. Environ. Microbiol. 1979, 38, 772-776.
63. Hult, K., Plestina, R., Habazin-Novak, V., Radic, B., Ceovic, S., Ochratoxin A in human blood and Balkan endemic nephropathy, Arch. Toxicol. 1982, 51, 313-321.
64. Fuchs, R., Radic, B., Ceovic, S., Sostaric, B., Hult, K., Human exposure to ochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 131-135.
65. Hult, K., Fuchs, F., Analysis and dynamics of ochratoxin A in biological systems, in: Steyn, P. S., Vlegaar, R. (Eds.), Mycotoxins and Phycotoxins, Elsevier Science, Amsterdam 1986, pp. 365-370.
66. Peraica, M., Domijan, M. A., Fuchs, R., Lucic, A., Radic, B., The occurence of ochratoxin A in blood in general population of Croatia, Toxicol. Lett. 1999, 110, 105-112.
67. Petkova-Bocharova, T., Chernozemsky, I. N., Castegnaro, M., Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria, Food Addit. Contam. 1988, 5, 299-301.
68. Petkova-Bocharova, T., Castegnaro, M., Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathv and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 135-137.
69. Castegnaro, M., Maru, V. Petkova-Bocharova, T., Nikolov, I., Bartsch, H., Concentration of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: Lack of detection of 4-hydroxyochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 165-169.
70. Petkova-Bocharova, T., Castegnaro, M., Pfohl-Leszkowiez, A., Garren, L. et al., Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan Endemic Nephropathy: A one month follow up study, Facta Univ. Ser. Med. Biol. 2003, 10, 62-68.
71. Vöö, S., Drugarin, D., Biriescu, A., Margineanu, F. et al., Increased ochratoxin A serum levels in patients with balkan nephropathy, Central Eur. J. Occup. Environ. Med. 2002, 8, 178-182.
72. Hald, B., Ochratoxin in human blood in European countries, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 159-164.
73. Creppy, E. E., Castegnaro, M., Grosse, Y., Étude de l'ochratoxicose humaine dans trois régions de France: Alsace, Aquitaine, et région Rhône, Alpes, in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext,colloque INSERM 1993, Vol. 231, pp. 147-158.
74. Bauer, G., Gareis, M., Ochratoxin A in der Nahrungsmittelkette, J. Vet. Med. B 1987, 34, 613-627.
75. Hadlock, R. M., Human ochratoxicosis in Germany: Updating 1993, in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, colloque INSERM 1993, Vol. 231, pp. 141-145.
76. Rosner, H., Rohrmann, B., Piker, G., Arch. lebensmittelhyg. 2000, 51, 104-107.
77. Breitholtz-Emanuelsson, A., Minervini, F., Hult, K., Visconti, A., Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from dif-ferent kidney disorders, Nat. Toxins 1994, 2, 366-370.
78. Palli, D., Miraglia, M., Saieva, C., Masala, G. et al., Serum levels of ochratoxin A in healthy adults in Tuscany: Correlation with individual characteristics and between repeat measurements, Cancer Epidemiol. Biomarkers Prev. 1999, 8, 265-269.
79. Golisnski, P., Ochratoxin A in human organism as a result of food and feed contamination, Rocz. AR Poznaniu 1987, 168, 1-61.
80. Jimenez, A. M., Lopez de Cerain, A., Gonzalez-Penas, E., Bello, J. et al., Exposure to ochatoxin in Europe: Comparison with a region of northern Spain, J. Toxicol. Toxin Rev. 1998, 17, 479-491.
81. Zimmerli, B., Dick, R., Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high, performance liquid chromatography with enhanced fluores-cence detection and immunoaffinity column cleanup: Method-ology and Swiss data, J. Chromatogr. 1995, 666, 85-99.
82. Breitholtz, A., Olsen, M., Dahlbäck, A., Hult, K., Plasma ochratoxin A levels in three Swedish populations surveyed using an ion, pair HPLC technique, Food Addit. Contam. 1991, 8, 183-192.
83. MacDonald, S. J., Langton, S., Brereton, P. A., Assessment of human exposure to ochratoxin in the UK - Relationship between dietary intake and plasma and urine, in: de Koe, W. J., Samson, R. A., van Egmond, H. P., Gilbert, J., Sabino, M. (Eds.), Proceeding of the Xth International IUPAC Symposium on Mycotoxins and Phycotoxins, 21-25 May, Guaruja, Brazil 2001, pp. 181-188.
84. Malir, F., Jergeova, Z., Severa, J., Cerna, M. et al., The level of ochratoxin A in blood serum of adults in the Czech republic, Rev. Méd. Vét. 1998, 149, 710-715.
85. Malir, F., Roubal, T., Brndiar, M., Osterreicher, J. et al., Ochratoxin A in the Czech republic, J. Toxicol. Toxin Rev. 2001, 20, 261-274.
86. Ruprich, J., Ostry, V., Health risk of the mycotoxin ochratoxin A to humans: Czech Republic-Brno-1991/92, Central Eur. J. Public Health 1993, 1, 86-93.
87. Ruprich, J., Ostry, V., Study of human exposure to ochratoxin A and assessement of possible source, Central Eur. J. Public Health 1993, 1, 46-48.
88. Kawamura, O., Maki, S., Sato, S., Ueno, Y., Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, colloque INSERM 1993, Vol. 231, pp. 158-165.
89. Märtlbauer, E., Usleber, E., Straka, M., Ochratoxin A im serum eines Lehrstuhlkollektivs: 1990-1995. Proceedings of the 18th Mycotoxin Workshop, 10-12 june 1996, Kulmbach, Germany 1996, pp. 97-101 (in German).
90. Schwerdt, G., Freudinger, R., Silbernagl, S., Gekle, M., Ochratoxin A-binding proteins in rat organs and plasma and different cell lines of the kidney, Toxicology 1999, 135, 1-10.
91. Stojkovic, R., Hult, S., Gamulin, R., Plestina, R., High affinity binding of ochratoxin A to plasma constituents, Biochem. Int. 1984, 9, 33-38.
92. Gilbert, J., Brereton, P., MacDonald, S., Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples, Food Addit. Contam. 2001, 18, 1088-1093.
93. Studer-Rohr, I., Schlatter, J., Dietrich, D. R., Kinetic Parameters and Intraindividual Fluctuations of ochratoxin A plasma levels in humans, Arch. Toxicol. 2000, 74, 499-510.
94. Scott, P. M., Kanhere, S. R., Lau, B. P., Lewis, D. A. et al., Survey of Canadian human blood plasma for ochratoxin A, Food Addit. Contam. 1998, 15, 555-562.
95. Gareis, M., Rosner, H., Ehrhardt, S., Blood serum levels of ochratoxin A and nutrition habits, Arch. Lebensmittelhyg. 2000, 51, 108-110.
96. Thuvander, A, Paulsen, J. E., Axberg, K., Johansson, N. et al., Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption, Food Chem. Toxicol. 2001, 39, 1145-1151.
97. Burdaspal, P. A., Legarda, T. M., Datos sobre la presencia de ocratoxina A enplasma humano en Espana, Alimentaria 1998, 292, 103-109 (in Spanish).
98. Gekle, M., Silbernagl, S., The role of the proximal tubule in ochratoxin A nephrotoxicity in vivo. Toxicodynamic and toxicokinetic aspects, Renal Physiol. Biochem. 1994, 17, 40-49.
99. Tsuda, M., Takashi, S., Takeda, M., Cha, S. H. et al., Transport of ochratoxin A by renal multi specific organic anion transporter, J. Pharmacol. Exp. Ther. 1999, 289, 1301-1305.
100. Jung, K. Y., Takeda, M., Kim, D. K., Tojo, A. et al., Characterization of ochratoxin A transport by human organic anion transporters, Life Sci. 2001, 69, 2123-2135.
101. Dahlman, A., Dantzler, W. H., Silbernagl, S., Gekle, M., Detailed mapping of ochratoxin A reabsorption along the rate nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanisms, J. Pharmacol. Exp. Ther. 1998, 286, 157-162.
102. Nikolov, I. G., Petkova-Bocharova, D., Castegnaro, M., Pfohl-Leskowicz, A. et al., Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy, J. Environ. Pathol. Toxicol. Oncol. 1996, 15, 201-207.
103. Pascale, M., Visconti, A., Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography, Mycopathologia 2001, 152, 91-95.
104. Fazekas, B., Tar, A., Kovacs, M., Ochratoxin A content of urine samples of human in Hungary, Acta Vet. Hun. 2005, 53, 35-44.
105. Jonsyn, F. E., Intake of aflatoxins and ochratoxins by infants in Sierra Leone: Possible effects on the general health of these children, J. Nutr. Environ. Med. 1999, 9, 15-22.
106. Jonsyn-Ellis, F. E., Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls, Mycopathologia 2000, 152, 35-40.
107. Gareis, M., Märtbauer, F., Bauer, J., Gedek, B., Determination of ochratoxin A in breast milk, Zeitschrift für Lebensmittel Untersuchung and Forschung 1988, 186, 114-117 (in German).
108. Kovács, F., Sandor, G., Vanyi, A., Domany, S., Zomborsky-Kovacs, M., Detection of ochratoxin A in human blood and colostrums, Acta Vet. Hung. 1995, 43, 393-400.
109. Skaug, M. A., Helland, I., Solvoll, K., Saugstad, O. D., Presence of ochratoxin A in human milk in relation to dietary intake, Food Addit. Contam. 2001, 18, 321-327.
110. Micco, M., Ambruzzi, A., Miraglia, M., Brera, C., Onori, R., Benelli, L., Contamination of human milk with ochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 105-108.
111. Micco, M., Miraglia, M., Brera, C., Corneli, S., Ambruzzi, A., Evaluation of ochratoxin A level in human milk in Italy, Food Addit. Contam. 1995, 12, 351-354.
112. Miraglia, M., de Dominicis, A., Brera, C., Corneli, S. et al., Ochratoxin A levels in human milk and related food samples: An exposure assessment, Nat. Toxins 1995, 3, 436-444.
113. Apostolou, E., El-Nezami, H. S., Ahokas, J. T., Donohue, D. C., The evaluation of ochrtatoxin A in human milk in Victoria (Australia), Rev. Méd. Vét. 1998, 149, 709-711.
114. Jonsyn, F. E., Maxwell, S. M., Hendricks, R. G., Ochratoxin A and aflatoxins in breast milk samples from Sierra Leone, Mycopatholgia 1995, 131, 121-126.
115. Navas, S. A., Sabino, M., Rodriguez-Amaya, D. B., Aflatoxin M1 and ochratoxin A in a human milk bank in the city of Sao Paulo, Brazil, Food Addit. Contam. 2005, 22, 457-462.
116. Postupolski, J., Karlowski, K., Contamination of human milk with ochratoxin A, Proceeding 20th Mykotoxin-Workshop, Detmold 1998, pp. 251-253.
117. Di Paolo, N., Guarnieri, A., Loi, F., Sacchi, G. et al., Acute renal failure from inhalation of mycotoxins, Nephron 1993, 64, 621-625.
118. Skaug, M. A., Eduard, W., Størmer, F. C., Ochratoxin in dust and fungal spores, Abstracts of the Xth International IUPAC Symposium on Mycotoxins and Phycotoxins, Guaruja, Brazil 2000, p. 123.
119. Skaug, M. A., Eduard W., Størmer, F. C., Ochratoxin in airborne dust and fungal conidia, Mycopathologia 2001, 151, 93-98.
120. Richard J. L., Plattner, R. D., May, J., Liska, S. L., The occurence of ochratoxin A in dust collected from a problem household Mycopathologia 1999, 146, 99-103.
121. Brera, C., Caputi, R., Miraglia, M., Iavicoli, I. et al., Exposure assessment to mycotoxins in workplaces: Aflatoxins and ochratoxin A occurrence in airborne dusts and human sera, Microchem. J. 2002, 73, 167-173.
122. Iavicoli, I., Brera, C., Carelli, G., Caputi, R. M. et al., External and internal dose in subjects occupationally exposed to ochratoxin A, Int. Arch. Occup. Environ. Health 2002, 75, 381-386.
123. Degen, G. H., Blaszkewicz, M., Lektarau, Y., Grüner, C., Induction of micronuclei with ochratoxin A in ovine seminal vesicle cells, Mycotoxin Res. 2003, 19, 3-7.
124. Bédouret, S., Molinié, A., Dunnigan, P., Castegnaro, M. et al., Contribution à l'amélioration de la qualité sanitaire du blé en cours de stockage. Suivi de la formation de mycotoxines, Partie 2: Programme de recherche relatif à leur contamination par des champignons toxinogènes producteurs d'ochratoxine, A., Phytoma, La défense des végétaux 2001, 541, 31-37.
125. Pohland, A. E., Nesheim, S., Friedman, L., Ochratoxin A, a review, Pure Appl. Chem. 1992, 64, 1029-1046.
126. Marquardt, R. R., Frohlich, A. A., A review of recent advances in understanding ochratoxicosis, J. Animal Sci. 1992, 70, 3968-3988.
127. Albassam, M. A., Yong, S. I., Bhatnagar, R., Sharma, A. K., Prior, M. G., Histopathologic and electron microscopic studies on the acute toxicity of ochratoxin A in rats Vet. Pathol. 1987, 24, 427-435.
128. Hagelberg, S., Hult, K., Fuchs, R., Toxicokinetics of ochratoxin A in several species and its plasma-binding properties, J. Appl. Toxicol. 1989, 9, 91-96.
129. Boorman, G., Hong, H. L., Dieter, M. P., Hayes, H. T. et al., Toxicol, Toxicol. Applied Pharmacol 1984, 72, 304-312.
130. Müller, G., Kielstein, P., Kohler, H., Berndt, A., Rosner, H., Studies on the influence of ochratoxin A in immune and defense reactions in the mouse model, Mycoses 1995, 38, 85-91.
131. Elling, F., Hald, B., Jacobsen, C., Krogh, P., Spontaneous cases of toxic nephropathy in poultry associated with Ochratoxin A, Acta Pathol. Microbiol. Scand. A 1975, 83, 739-741.
132. Prior, M. G., O'Neil, J. B., Sisodia, C. S., Effects of ochratoxin A on growth response and residues in broilers, Poultry Sci. 1980, 59, 1254-1257.
133. Prior, M. G., Sisodia, C. S., Ochratoxicosis in White Leghorn hens, Poultry Sci. 1978, 57, 619-623.
134. Gibson, R. M., Bailey, C. A., Kubena, L. F., Huff, W. E., Harvey, R. B., Ochratoxin A and dietary protein. 1. Effects on body weight, feed conversion, relative organ weight, and mortality in three-week-old broilers, Poultry Sci. 1989, 68, 1658-1663.
135. Gibson, R. M., Bailey, C. A., Kubena, L. F., Huff, W. E., Harvey, R. B., Impact of L-phenylalanine supplementation on the performance of three-week-old broilers fed diets containing ochratoxin, A. 1. Effects on body weight, feed conversion, relative organ weight and mortality, Poultry Sci. 1990, 69, 414-419.
136. Dwivedi, P., Burns, R. B., Effect of ochratoxin A on immunoglobulins in broiler chickens, Res. Vet. Sci. 1984, 36, 117-121.
137. Dwivedi, P., Burns, R. B., Pathology of ochratoxicosis in young broiler chicks, Res. Vet. Sci. 1984, 36, 92-103.
138. Bailey, C. A., Gibson, R. M., Kubena, L. F., Huff, W. E., Harvey, R. B., Ochratoxin A and dietary protein. 2: Effects on hematology and clinical chemistry measurements, Poultry Sci. 1989, 68, 1664-1671.
139. Haazele, F. M., Guenter, W., Marquardt, R., Frohlich, A. A., Beneficial effects of dietary ascorbic acid supplement on hens subjective to ochratoxin A toxicosis under normal and high ambient temperature, Can. J. Animal Sci. 1993, 73, 149-157.
140. Molinié, A., Evaluation de l'effet synergique de mycotoxines de stockage (ochratoxine A, citrinine, acide pénicillique) Ph.D. Thesis, Institut National Polytechnique Toulouse, France, Juillet 2004.
141. 1. Development of a new method for simultaneous extraction of ochratoxin A and citrinine, Food Chem. 2005, 92, 391-400.
142. 1 in breakfast cereals collected in french market. Comparison of OTA analysis using or not immunoaffinity clean-up before HPLC, Revista Mexicana de Micologia 2004, 19, 7-15.
143. Frank, H. K., Citrinin, Z. Ernährungswiss. 1992, 31, 164-177.
144. Krogh, P., Ochratoxins: Occurrence, biological effects and causal role in disease, in: Eaker, D., Wadstrom, T., Natural Toxins, Pergamon Press, Oxford 1980, pp. 673-680.
145. Sujani, N. G., Sriraman, P. K., Pathology of ochratoxicosis in quails, Indian J. Animal Sci. 2000, 70, 1120-1122.
146. Ribelin, W. E., Fukushima, K., Still, P., The toxicity of ochratoxin A to ruminants, Can. J. Compar. Med. 1978, 42, 172-176.
147. Krogh, P., Hald, B., Pedersen, E. J., Occurrence of ochratoxin A and citrinin in cereals associated, with mycotoxic porcine nephropathy, Acta Pathol. Microbiol. Scand. B 1973, 81, 689-695.
148. Krogh, P., Axelsen, N. H., Elling, F., Gyrd-Hansen, N. et al., Experimental porcine nephropathy changes of renal function and structure induced by ochratoxin A-contaminated feed. Acta Pathol. Microbiol. Scand. A 1974, Suppl. 246, 1-21.
149. Elling, F., Nielsen, J. P., Lillehoj, E. B., Thomassen, M. S., Størmer, F., Ochratoxin A induced porcine nephropathy: Enzyme and ultrastructure changes after short-term exposure, Toxicon 1985, 23, 247-254.
150. Harvey, R. B., Huff, W. E., Kubena, L. F., Phillipps, T. D., Immunotoxicity of ochratoxin A to growing gilts, Am. J. Vet. Res. 1989, 50, 1400-1405.
151. Szczech, G. M., Carlton, W. W., Tuite, J., Caldwell, R., Ochratoxin A toxicosis in swine, Vet. Pathol. 1973, 10, 347-364.
152. Stoev, S. D., Experimental mycotoxic nephropathy in pigs, Vet. Med. 1997, 1-2, 102-107.
153. Stoev, S. D., The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation, Vet. Human Toxicol. 1998, 40, 352-360.
154. Stoev, S. D., Grozeva, N., Hald, B., Ultrastructural and toxicological investigations in spontaneous cases of porcine nephropathy in Bulgaria, Veterinarski 1998, 68, 39-49.
155. Stoev, S. D., Vitanov, S., Anguelov, G., Petkova Bocharova, T., Creppy, E. E., Experimental porcine nephropathy in pigs provoked by a diet containing ochratoxin A and Penicillic acid, Vet. Res. Commun. 2001, 25, 205-223.
156. Stoev, S. D., Paskalev, M., MacDonald, S., Mantle, P. G., Experimental 1 year ochratoxin A toxicosis in pigs, Exp. Toxicol. Pathol. 2002, 53, 481-487.
157. Biró, K., Solti, L., Varna-Vetró, I., Bagó, G. et al., Tissue distribution of ochratoxin A as determined by HPLC and Elisa and hystopathological effects in chickens, Avian Pathol. 2002, 31, 141-148.
158. Stoev, S. D., Daskalov, H., Radic, B., Domijan, A. M., Peraica, M., Spontaneous mycotoxic nephropathy in Bulgarian chickens with inclarified mycotoxin etiology, Vet. Res. 2002, 33, 83-93.
159. Munro, C., Moodie, A., Kuiper-Goodman, T., Scott, P. M., Grice, H. C., Toxicologic changes in rats fed graded dietary levels of ochratoxin A, Toxicol. Appl. Pharmacol. 1974, 28, 180-188.
160. Hamilton, P. B., Huff, W. E., Harris, J. R., Wyatt, R. D., Natural occurrences of ochratoxicosis in poultry, Poultry Sci. 1982, 61, 1832-1837.
161. Huff, W. E., Wyatt, R. D., Hamilton, P. B., Nephrotoxicity of dietary ochratoxin A in broiler chickens, Appl. Microbiol. 1975, 30, 48-54.
162. Burns, R. B., Maxwell, M. H., Ochratoxicosis A in young Khabi Campbell ducklings, Res. Vet. Sci. 1987, 42, 395-402.
163. Maxwell, M. H., Burns, R. B., Dwiedi, P., Ultrastructural study of ochratoxicosis in turkey poults, Poultry Sci. 1987, 60, 144-118.
164. Lea, T., Steien, K., Størmer, F. C., Mechanism of ochratoxin A induced immunosuppression, Mycopathologia 1989, 107, 153-159.
165. Luster, M. I., Germolec, D. R., Burleson, G. R., Jameson, C. W. et al., Selective immunosuppressions in mice of natural killer cell activity by ochratoxin A, Cancer Res. 1987, 47, 2259-2263.
166. Heller, M., Rosner, H., Burkert, B., Möller, U. et al., In vitro studies into the influence of ochratoxin A on the production of tumor necrosis factor a by the human monocytic cell line THP-1, Deutche Tierärztl. Wschr. 2002, 109, 200-205.
167. Weidenbach, A., Schuh, K, Failing, K., Petzinger, E., Ochratoxin A induced TNF release from the isolated and blood-free perfused rat liver, Mycotoxin Res. 2000, 16A, 189-193.
168. Al-Anati, L., Katz, N., Petzinger, E., Interference of arachidonic acid and its metabolites with TNF release by ochratoxin A from rat liver, Toxicology 2005, 208, 335-346.
169. Szczech, G. M., Carlton, W. W., Tuite, J., Ochratoxicosis in beagle dogs. II Pathology, Vet. Pathol. 1973, 10, 219-231.
170. Chang, C. F., Huff, W. E., Hamilton, P. B., A leucocytopenia induced in chikens by dietary ochratoxin A, Poultry Sci. 1979, 58, 555-558.
171. Dwivedi, P., Burns, R. B., Immunosuppressive effects of ochratoxin A in young turkeys, Avian Pathol. 1985, 14, 213-225.
172. Krogh, P., Mycotoxic nephropathy, Adv. Vet. Sci. Compar. Med. 1976, 20, 147-153.
173. Krogh, P., Elling, F., Friis, C., Hald, B. et al., Porcine
174. Hult, K., Hökby, E., Gatenbeck, S., Rutqvist, L., Ochratoxin A in pig blood: Method of analysis and use as a tool for feed studies, Appl. Environ. Microbiol. 1980, 39, 828-830.
175. Hult, T. K., Rutqvist, L., Holmberg, T., Thafvelin, B., Gatenbeck, S., Ochratoxin in blood of slaughter pigs, Nord. Vet. Med. 1984, 36, 314-316.
176. Harvey, B. B., Elissalde, M. H., Kubena, L. F., Weaver, E. A., Corrier de Clerment, B. A., Immunotoxicity of ochratoxin A to growing gilts, Am. J. Vet. Res. 1992, 53, 1966-1970.
177. Holmberg, T., Thuvander, A., Hult, K., Ochratoxin A as a suppressor of mitogen-induced blastogenesis of procine blood lymphocytes, Acta Vet. Scand. 1988, 29, 219-225.
178. Hong, H. H. L., Jameson, C. W., Boorman, G. A., Residual hematopoietic effect in mice exposed to ochratoxin A prior to irradiation, Toxicology 1988, 53, 57-67.
179. Chang, C. F., Impaired phagocytosis by monocytes from fowls with ochratoxicosis, J. Chin. Soc. Vet. Sci. 1982, 8, 19-24.
180. Chang, C. F., Hamilton, P. B., Impairment of phagocytosis by heterophils from chickens during ochrtatoxicosis, Appl. Environ. Microbiol. 1980, 38, 572-575.
181. Patterson, D. S. P., Shreeve, B. J., Roberts, A. B., Brush, P. J. et al., Effect on calves of barley naturally contaminated with ochratoxin A and groundnut meal contaminated by low concentration of aflatoxin B1, Res. Vet. Sci. 1981, 31, 213-218.
182. Stoev, S. D., Goundasheva, D., Mirtcheva, T., Mantle, P., Susceptibility to bacterial infections in growing pigs as an early response in ochratoxicosis, Exp. Toxicol. Pathol. 2000, 52, 287-296.
183. Müller, G., Kielstein, P., Rosner, H., Berndt, A. et al., Studies of the influence of ochratoxin A on immune and defence reactions in weaners, Mycoses 1999, 42, 495-505.
184. Müller, G., Kielstein, P., Rosner, H., Kohler, H. et al., Beeinflussen Mikotoxin die Immune- und- Abwehrreaktionen des Schweines? Prakt. Tierarzt 2000, 81, 932-940 (in German).
185. Stoev, S. D., Koynarski, V., Mantle, P. G., Clinicomorphological studies in chicks fed ochratoxin A while simultaneously developing coccidiosis, Vet. Res. Commun. 2002, 26, 189-204.
186. Stoev, S. D., Anguelov, G., Ivanov, I., Pavlov, D., Influence of ochratoxin A and an extract of artichoke on the vaccinal immunity and health in broiler chicks, Exp. Toxicol. Pathol. 2000, 52, 43-55.
187. Haubeck, H. D., Lorkowki, G., Kolsch, E., Röschenthaler, R., Immunosuppression by ochratoxin A and its prevention by phenylalanine, Appl. Environ. Microbiol. 1987, 41, 1040-1042.
188. Thuvander, A., Breitholtz-Emanuelsson, A., Olsen, M., Effects of ochratoxin A on the mouse immune system after subchronic exposure, Food Chem. Toxicol. 1995, 33, 1005-1011.
189. Thuvander, A., Breitholtz-Emmanuelson, A., Brbencova, D., Gadhasson, I., Prenatal exposure of Balbc/C mice to ochratoxin A: Effects on the immune system in the offspring, Food Chem. Toxicol. 1996, 34, 547-554.
190. 1 pour son potentiel de décontamination en ochratoxine A du blé: Les effets toxiques liés à une exposition subchronique à l'ochratoxine A sont-ils atténués suite au traitement du blé par le procédé, Ph.D. Thesis, Institut National Polytechnique de Toulouse, France, Juillet 2006.
191. Gaou, I., Dubois, M., Pfohl-Leszkowicz, A., Coste, C., Parent-Massin, D., Safety of Oxygreen, an ozone treatment on wheat grains. Part 1. A four-week toxicity study in rats by dietary administration of treated wheat, Food Addit. Contam. 2005, 22, 1113-1119.
192. Singh, G. S., Chauhan, H. V., Jha, G. J., Singh, K. K., Immunosuppression due to chronic ochratoxicosis in broiler chicks, Pathology 1990, 103, 399-410.
193. Hayes, A. W., Hood, R. D., Lee, H. L., Teratogenic effects of ochratoxin A in mice, Teratology 1974, 9, 93-98.
194. Brown, M. H., Szczeck, G. M., Purmalis, B. P., Teratogenic and toxic effets of ochratoxin A in rats, Toxicol. Appl. Pharmacol. 1976, 37, 331-338.
195. Mayura, K., Reddy, R. V., Hayes, A. W., Berndt, W. O., Teratogenic and toxic effects of ochratoxin A in rats, Toxicol. Appl. Pharmacol. 1976, 37, 331-338.
196. Abdel-Wahhab, M. A., Nada, S. A., Arbid, M. S., Ochratoxicosis: Prevention development toxicity by L-methionine in rats, J. Appl. Toxicol. 1999, 19, 7-12.
197. Hood, R. D., Naughton, M. J., Hayes, A. W., Teratogenic effects of Ochratoxin A in hamsters, Teratology 1975, 11, 23A.
198. Hood, R. D., Naughton, M. J., Hayes, A. W., Prenatal effects of Ochratoxin A in hamsters, Teratology 1976, 13, 11-14.
199. Gilani, S. H., Bancroft, J., Reily, M., Teratogenicity of ochratoxin A in chick embryos, Toxicol. Appl. Pharmacol. 1978, 46, 543-546.
200. Wangikar, P. B., Dwivedi, P., Sinha, N., Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects World Rabbit Sci. 2004, 12, 159-171.
201. Shreeve, B. J., Patterson, D. S. P., Pepin, G. A., Roberts, B. A., Wzathall, A. E., Effect of feeding ochratoxin to pigs during early pregnancy, Br. Vet. J. 1977, 133, 412-417.
202. Kuiper-Goodman, T., Scott, P. M., Risk assessment of the mycotoxin ochratoxin A, Biomed. Environ. Sci. 1989, 2, 179-248.
203. Mayura, K., Reddy, R. V., Hayes, A. W., Berndt, W. O., Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats, Toxicology 1982, 25, 175-185.
204. Mayura, K., Stein, A. F., Berndt, W. O., Phillips, T. D., Teratogenic effects of ochratoxin A in rats with impaired renal function, Toxicology 1984, 32, 277-285.
205. Wei, X., Sulik, K. K., Pathogenesis of craniofacial and body wall malformation induced by ochratoxin A, Am. J. Med. Genet. 1993, 47, 862-871.
206. Fukui, Y., Hoshino, K., Kameyama, Y., Yasui, T. et al., Placental transfer of ochratoxin A and its cytotoxic effect on the mouse embryonic brain, Food Chem. Toxicol. 1987, 25, 17-24.
207. Szczech, C. M., Hood, R. D., Brain necrosis in mouse fetuses transplacentally exposed to the mycotoxin ochratoxin A, Toxicol. Appl. Pharmacol. 1981, 57, 127-137.
208. Patil, R. D., Dwivedi, P., Sharma, A. K., Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats, Reprod. Toxicol. 2006, 22, 679-687.
209. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 56: Some Naturally Occurring Substances: Some Food Items And Constituents, Heterocyclic Aromatic Amines And Mycotoxins, IARC, Lyon, France 1993.
210. Purchase, I. F. H., Van der Watt, J. J., The long term toxicity of ochratoxin A to rats, Food Chem. Toxicol. 1971, 9, 681-682.
211. Doster, R. C., Sinnhuber, R. O., Pawlowski, N. E., Acute toxicity and carcinogenicity of ochratoxin A in rainbow trout (Salmo garidneri), Food Cosmet. Toxicol. 1974, 12, 499-505.
212. Dickens, F., Waynforth, H. B., Studies on carcinogenesis of lactones and related substances, Report of the British Empire Cancer Campaign 1968, 46, 108-110.
213. Kanisawa, M., Suzuki, S., Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin, Gann 1978, 69, 599-600.
214. IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Man, Volume 10: Some Naturally Occurring Substances, IARC, Lyon, France 1976.
215. IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans, Volume 31: Some Food Additives, Feed Additives And Naturally Occurring Substances, IARC, Lyon, France 1983.
216. Kanisawa, M., Synergistic effect of citrinin on hepatorenal carcinogenesis of ochratoxin A in mice, Dev. Food Sci. 1984, 7, 245-254.
217. Bendele, A. M., Carlton, W. W., Krogh, P., Lillehoj, E. B., Ochratoxin A carcinogenesis in the (C57B1/6J x C3H)F1 mouse, J. Nat. Cancer Int. 1985, 75, 733-742.
218. Boorman, G. (Ed.), NTP technical report on the toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). NIH Publication No. 89-2813. U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC 1989.
219. Castegnaro, M., Mohr, U., Pfohl-Leszkowicz, A., Esteve, J. et al., Strain- and sex-specific induction of renal tumours by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77, 70-75.
220. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U., Castegnaro, M., Sex- and strain-specific expression of CYPs involved in ochratoxin A genotoxicity and carcinogenicity in rats, Mol. Carcinog. 1998, 23, 78-85.
221. Hilgard, P., Burkert, H., Sodium-2-mercaptosulfonate (MESNA) and ifosfamide nephrotoxicity, Eur. J. Cancer Clin. Oncol. 1984, 20, 1452-1452.
222. Kempf, S. R., Ivankovic, S., Wiessler, M., Schmähl, D., Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats, Br. J. Cancer 1985, 52, 937-939.
223. Pfohl-Leszkowicz, A., Bartsch, H., Azémar, B., Mohr, U. et al., MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways, Facta Univ. Ser. Med. Biol. 2002, 9, 57-63.
224. Mantle, P., Kulinskaya, E., Nestler, S., Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A, Food Addit. Contam. 2005, Suppl. 1, 58-64.
225. DFG. Deutche Forschungsgemeinschaft List of MAK and BAT Values, Commission for the investigation of Health Hazards of chemical compounds in the work area, report no. 39, Wiley-VCH, Verlag Weinheim 2003.
226. Schwartz, G. G., Hypothesis: Does ochratoxin A cause testicular cancer? Cancer Causes Control 2001, 13, 91-100.
227. Pfohl-Leszkowicz, A., Castegnaro, M., Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation, Food Addit. Contam. 2005, Suppl. 1, 75-87.
228. Son, W. C., Kamino, K., Lee, Y. S., Kang, K. S., Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats, Int. J. Cancer 2003, 105, 305-311.
229. Kumagai, S., Aibara, K., Intestinal absorption and secretion of ochratoxin A in the rat, Toxicol. Appl. Pharmacol. 1982, 64, 94-102.
230. Ringot, D., Chango, A., Schneider, Y.-J., Larondelle, Y., Toxicokinetics and toxicodynamics of ochratoxin A, an update, Chem. Biol. Interact. 2006, 159, 18-46.
231. O'Brien, E., Dietrich, D. R., Ochratoxin A: The continuing enigma, Crit. Rev. Toxicol. 2005, 35, 33-60.
232. Stein, A. F., Phillips, T. D., Kubena, L. F., Harvey, R. B., Renal tubular secretion and readsorption as factors in ochratoxicosis: Effects of probenicid on nephrotoxicity, J. Toxicol. Environ. Health 1985, 16, 593-600.
233. Gekle, M., Sauvant, C., Schwerdt, G., Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells, Mol. Nutr. Food Res. 2005, 49, 118-130.
234. Galtier, P., Charpenteau, J. L., Alvinerie, M., Labouche, C., The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration, Drug Metab. Dispos. 1979, 7, 429-434.
235. Roth, A., Chakor, K., Creppy, E. E., Kane, A. et al., Evidence of an enterohepatic circulation of ochratoxinA in mice, Toxicology 1988, 48, 293-308.
236. Berger, V., Gabriel, A. F., Sergent, T., Trouet, A. et al., Interaction of ochratoxin Awith human intestinalCaCo-A.2 cells: Possible implication of a multidrug resistanceassociatedproteins (MRP2), Toxicol. Lett. 2003, 140-141, 465-476.
237. Schrickx, J., Lektarau, Y., Fink-Gremmels, J., Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells, Arch. Toxicol. 2006, 80, 243-249.
238. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van De Vijver, M. J. et al., Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues, Cancer Res. 2001, 61, 3458-3464.
239. Jonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E. et al., The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk, Nat. Med. 2005, 11, 127-129.
240. Galtier, P., Alvinerie, M., Charpenteau, J. L., The pharmacokineticprofiles of ochratoxin A in pigs, rabbit and chicken, Food Cosmet. Toxicol. 1981, 19, 735-738.
241. Sergent, T., Garsou, S., Schaut, A., Saeger, S. D. et al., Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations, Toxicol. Lett. 2005, 159, 60-70.
242. Chu, F. S., Interaction of ochratoxin A with bovine serum albumine, Arch. Biochem. Biophys. 1971, 147, 359-366.
243. Chu, F. S., A comparative study of the interaction of ochratoxinswith bovine serum albumine, Biochem. Pharmacol. 1974, 25, 1105-1107.
244. Kumagai, S., Ochratoxin A: Plasma concentration and excretion into bile and urine in albumin-deficient rats, Food Chem. Toxicol. 1985, 23, 941-943.
245. Heussner, A. H., O'Brien, E., Dietrich, D. R., Species and sex-specific variations in binding of ochratoxin A by renal proteins in vitro, Exp. Toxicol. Pathol. 2002, 54, 151-160.
246. Il'ichev, Y. V., Perry, J. L., Simon, J. D., Interaction of ochratoxin Awith human serum albumin. Preferential binding of the dianion and pH effects, J. Phys. Chem. B 2002, 106, 452-459.
247. Il'ichev, Y. V., Perry, J. L., Rüker, F., Dockal, M., Simon, J. D., Interaction of ochratoxin A with human serum albumin. Binding sites localised by competitive interactions with the native protein and its recombinant fragment, Chem. Biol. Interact. 2002, 141, 275-293.
248. Simon, J. D., Perry, J. L., Il'ichev, Y. V., Pritchard, J. B., Bow, D. A. J., Binding of ochratoxin A to human plasma proteins: Implications in toxicity mechanisms, Biophys. J. 2003, 85, 332A.
249. Dai, J., Park, G., Perry, J. L., Il'ichev, Y. V. et al., Molecular aspects of the transport and toxicity of ochratoxin A, Acc. Chem. Res. 2004, 37, 874-881.
250. Petzinger, E., Ziegler, K., Ochratoxin A from a toxicological perspective, J. Vet. Pharmacol. Ther. 2000, 23, 91-98.
251. Stander, A. M., Nieuwoudt, T. W., Steyn, P. S., Shepard, G. S. et al., Toxicokinetics of ochratoxin A in vervet monkeys (Cercopithecus aethiops), Arch. Toxicol. 2001, 75, 262-269.
252. Schlatter, C., Studer-Rohr, J., Rasonyi, T., Carcinogenicity and kinetic aspects of Ochratoxin A, Food Add. Contam. 1996, 13, 43-44.
253. Li, A., Marquardt, S., Frohlich, A., Vitti, T. G., Crow, G., Pharmacokinetics of ochratoxin A and its metabolites in rats, Toxicol. Appl. Pharmacol. 1997, 145, 82-90.
254. Harwing, J., Kuiper-Goodman, T., Scott, P. M., Microbial food toxicant: Ochratoxins, in: Rechcigl, M. (Ed.), Handbook of Foodborne Diseases of Biological Origin, CRC Press, Boca Raton, USA 1983, pp. 192-238.
255. Ferrufino-Guardia, E. V., Tangni, E. K., Larondelle, Y., Ponchaut, S., Transfer of ochratoxin A during lactation: Exposure of suckling via milk of rabbit does fed a naturally contamined feed, Food Addit. Contam. 2000, 17, 167-175.
256. Madsen, A., Mortensen, H. P., Hald, B., Feeding experiments with ochratoxin A contamined barley for bacon pigs, influence on pig performance and residues, Acta Agric. Scand. 1982, 32, 225-239.
257. Mortensen, H. P., Hald, B., Larsen, A. E., Madsen, A., Ochratoxin A contaminated barley for sows and piglets. Pig performance and residues in milk and pigs, Acta Agric. Scand. 1983, 33, 349-352.
258. Kane, A., Creppy, E. E., Roth, A., Röschenthaler, R., Dirheimer, G., Distribution of the [3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys, Arch. Toxicol. 1986, 58, 219-224.
259. 14C-ochratoxin B and a comparative study of their distribution in rats using whole-body autoradiography, Pharmacol. Toxicol. 1992, 70, 255-261.
260. 14C-ochratoxin A in the mouse monitored by whole-body autoradiography, Pharmacol. Toxicol. 1988, 63, 355-360.
261. 1; étude toxicologique. Récents progrès en génie des procédés, 92, Lavoisier, Paris 2005, ISBN 2-91023966-7.
262. 1 process applied on wheat can reduce Ochratoxin A contamination, Proceeding of 7th World Congress of Chemical engineering, SECC-Glasgow-Scotland 2005, http:// 127.0.0.1:103/cgi-bin/somsid.exe.
263. 1 process for mycotoxin decontamination: Example of Ochratoxin A, Proceeding of Euro-Magrebin Symposium on biological, Chemical Contaminant and safety on Food, Fez, Morocco, 7-9 September 2005.
264. Hallen, I. P., Breitholtz-Emanuelsson, A., Hult, K., Olsen, M., Oskarsson, A., Placental and lactational transfer of Ochratoxin A in rats, Nat. Toxins 1998, 6, 43-49.
265. Appelgreen, L. E., Arora, R. G., Distribution of 14C-labelled ochratoxin A in pregnant mice, Food Chem. Toxicol. 1983, 21, 563-568.
266. Miraglia, M., Brera, C., Corneli, S., Cava, E. et al., Occurence of ochratoxin A (OTA) in maternal serum, placenta and funiculum, in: Miraglia, M., van Egmond, H., Brera, C., Gilbert J. (Eds.), Proceedings of IX International IUPAC Symposium on Mycotoxins and Phycotoxins-Developments in Chemistry, Toxicology and Food Safety, Alaken Inc., USA 1998, pp. 165-179.
267. Cha, S. H., Sekine, T., Kusushura, H., Yu, E. et al., Molecular cloningand characterization of multispecific organic anion transporter 4 expressed in the placenta, J. Biol. Chem. 2000, 275, 4507-4512.
268. Turconi, G., Guarcello, M, Livieri, C., Comizzoli, S. et al., Evaluation of xenobiotics in human milk and ingestion by the newborn- an epidemiological survey in Lombardy (Northern Italy), Eur. J. Nutr. 2004, 43, 191-197.
269. Støren, O., Holm, H., Størmer, F. C., Metabolism of ochratoxin A by rats, Appl. Environ. Microbiol. 1982, 44, 785-789.
270. Moroi, K., Suzuki, S., Kuga, T., Yamazaki, M., Kanizawa, M., Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital, Toxicol. Lett. 1985, 25, 1-5.
271. Bow, D. A. J., Perry, J. L., Simon, J. D., Pritchard, J. B., The impact of plasma protein binding on the renal transport of organic anions, J. Pharmacol. Exp. Ther. 2006, 316, 349-355.
272. Russel, F. G., Masereeuw, R., van Aubel, R. A., Molecular aspect of renal anionic drug transport, Annu. Rev. Physiol. 2002, 64, 563-594.
273. Leier, I., Hummel-Eisenbeiss, J., Cui, Y., Keppler, D., ATP dependent para-aminohippurate transport by apical multidrug resistance protein MRP2, Kidney Int. 2000, 57, 1636-1642.
274. Kobayashi, Y., Okuda, T., Fujioka, Y., Matsumura, G. et al., Differential gene expression of organic anion transporters in male and female rats, Biochem. Biophys. Res. Commun. 2002, 290, 482-487.
275. Miyazaki, H., Sekine, T., Endou, H., The multispecific organic anion transporter family: Properties and pharmacological significance, Trends Pharmacol. Sci. 2004, 25, 654-666.
276. Schinkel, A. H., Jonker, J. W., Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview, Adv. Drug Deliv. Rev. 2003, 55, 3-29.
277. Groves, C. E., Morales, M., Wright, S. H., Peritubular transport of ochratoxin A in rabbit renal proximal tubules, J. Pharmacol. Exp. Ther. 1998, 284, 943-948.
278. Sweet, D. H., Miller, D. S., Pritchard, J. B., Localization of an anorganic anion transporter GFP fusion construct (rOAT1-GFP) in intact proximal tubules, Am. J. Physiol. Renal Physiol. 1999, 276, F864-F873.
279. Sweet, D. H., Chan, L. M. S., Walden, R., Yang, X. et al., Organic anion transporter 3 (SLC22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient, Am. J. Physiol. Renal Physiol. 2003, 284, F763-F769.
280. Kusushura, H., Sekine, T., Utsunomiya-Tate, N. M., Tsuda, M. et al., Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain, J. Biol. Chem. 1999, 274, 13675-13680.
281. Buist, S. C. N., Klaassen, C. D., Rat and mouse differences in gender-predominant expression of organic anion transporter (oat1-3 slc22a6-8) mRNA levels, Drug Metab. Dispos. 2004, 32, 620-625.
282. Buist, S. C. N., Gender-specific and developmental influences on the expression of rat organic anion transporters, J. Pharmacol. Exp. Ther. 2002, 301, 145-151.
283. Koepsell, H., Endou, H., The SLC22 drug transporter family, Eur. J. Physiol. 2003, 447, 666-676.
284. Bahnemann, E., Kerling, H. P., Ensminger, S., Schwerdt, G. et al., Renal transepithelial secretion of ochratoxinA in the non-filtering toad kidney, Toxicology 1997, 120, 11-17.
285. Chandra, P., Brouwer, K. L. R., The complexities of hepatic drug transport: Current knowledge and emerging concepts, Pharm. Concepts 2004, 21, 719-735.
286. Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y. et al., Role of human anio transporter 4 in the transport of ochratoxin A, Biochim. Biophys. Acta 2002, 1590, 64-75.
287. Zingerle, M., Silbernagl, S., Gekle, M., Reabsorption of the nephrotoxin ochratoxin A along the rat nephron in vivo, J. Pharmacol. Exp. Ther. 1997, 280, 220-224.
288. Takeuchi, A., Masuda, S., Saito, H., Abe, T., Inui, K. I., Multispecificsubstrate recognition of kidney-specific organic aniontransporters OAT-K1 and OAT-K2, J. Pharmacol. Exp. Ther. 2001, 299, 261-267.
289. Youngblood, G. L., Sweet, D. H., Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney, Am. J. Physiol. Renal Physiol. 2004, 287, F236-F244.
290. Schwerdt, G., Gekle, M., Freudinger, R., Mildenberger, S., Silbernag, S., Apical-to-basolateral transepithelial transport of ochratoxinA by two subtypes of Madin-Darby canine kidney cells, Biochem. Biophys. Acta 1997, 1324, 191-199.
291. Størmer, F. C., Ochratoxin, A., A mycotoxin of concern, in, Bhatnagar, D., Lillehoj, E. B., Arora, D. K. (Eds.), Handbook of Applied Mycology, Marcel Dekker, New York 1992, pp. 403-432.
292. Størmer, F. C., Pederson, J. I., Formation of 4-OH-ochratoxin A from ochratoxin A by rat liver microsomes, Appl. Environ. Microbiol. 1980, 39, 971-975.
293. Størmer, F. C., Støren, O., Hansen, C. E., Pedersen, J. I. et al., Formation of (4R)- and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species, Appl. Environ. Microbiol. 1981, 42, 1051-1056.
294. Størmer, F. C., Hansen, C. E., Pedersen, J. I., Aasen, J., Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes, Appl. Environ. Microbiol. 1983, 45, 1183-1187.
295. Hansen, C. E., Dueland, S., Drevon, C. A., Størmer, F. C., Metabolism of ochratoxin A by primary cultures of rat hepatocytes, Appl. Environ. Microbiol. 1982, 43, 1267-1271.
296. Fink-Gremmels, J., Blom, M., Woutersen van Nijnanten, F., Comparative aspect of ochratoxin A metabolism, in: Scudamore, P. (Ed.), Proceedings of UK Workshop Occurrence and Significance of Mycotoxins, London 1993, pp. 124-127.
297. Fink-Gremmels, J., Blom, M., Woutersen van Nijnanten, F., In vitro investigations on ochratoxin A metabolism, in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, colloque INSERM 1993, Vol. 231, pp. 67-74.
298. Hutchinson, R. D., Steyn, P. S., The isolation and structure of 4-hydroxyochratoxin A and 7-carboxy-3,4-dihydro-8-hydroxy-3-methylisocoumarin from Penicillium viridicatum, Tetrahedron Lett. 1971, 43, 4033-4036.
299. Suzuki, S., Moroi, K., Kanisawa, M., Satoh, T., The pharmacokinetics of ochratoxin A in rats, Jpn. J. Pharmacol. 1977, 27, 735-744.
300. Pitout, M. J., The hydrolysis of ochratoxin A by some proteolytic enzymes, Biochem. Pharmacol. 1969, 18, 1829-1836.
301. Petkova-Bocharova, T., El Adlouni, C., Faucet, V., Pfohl-Leszkowicz, A., Mantle, P., Analysis for DNA adducts, ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis, Facta Univ. Ser. Med. Biol. 2003, 10, 111-115.
302. Faucet, V., El Adlouni, C., Dekant, W., Castegnaro, M., Pfohl-Leszkowicz, A., Correlation between ochratoxin A-metabolites produced by several pig organs microsomes and DNA-adduct formation, Drug Metab. Rev. 2003, 35, 112.
303. Hietanen, E., Malaveille, C., Camus, A.-M., Béréziat, J. C. et al., Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-medated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine, Drug Metab. Dispos. 1986, 14, 118-126.
304. Pfohl-Leszkowicz, A., Grosse, Y., Obrecht, S., Kane, A. et al., Preponderance of DNA adducts in kidney after ochratoxin A exposure, in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, colloque INSERM 1993, Vol. 231, pp. 199-207.
305. El Adlouni, C., Pinelli, E., Azémar, B., Zaoui, D. et al., Role of CYP 2C and microsomal glutathione-S-transferase in modulating susceptibility to ochratoxin A genotoxicity, Environ. Mol. Mutagen. 2000, 35, 123-131.
306. Pinelli, E., El Adlouni, C., Pipy, B., Quartulli, F., Pfohl-Leszkowicz, A., Respective implication of cyclooxygenase in ochratoxin A genotoxicity on human epithelial lung cells, Environ. Toxicol. Pharmacol. 1999, 7, 95-107.
307. Grosse, Y., Baudrimont, I., Castegnaro, M., Creppy, E. E. et al., Ochratoxin A metabolites and DNA-adducts formation in monkey kidney cell, Chem. Biol. Interact. 1995, 95, 175-187.
308. Fink-Gremmels, J., Jahn, A., Blom, M., Toxicity and metabolism of ochratoxin A, Nat. Toxins 1995, 3, 214-220.
309. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., Metzler, M., Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes, J. Agric. Food Chem. 2002, 50, 938-945.
310. Gillman, I. G., Yezek, J. M., Manderville, R. A., Ochratoxin A acts as a photoactivatable DNA cleaving agent, Chem. Commun. 1998, 647-648.
311. Brow, M. E., Dai, J., Park, G., Wright, M. W. et al., Photochemically catalysed reaction of ochratoxin A with D- and L-cysteine, Photochem. Photobiol. 2002, 76, 649-656.
312. Guengerich, F. P., Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity, Chem. Res. Toxicol. 2001, 14, 611-650.
313. Manderville, R. A., A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction, Chem. Res. Toxicol. 2005, 18, 1091-1097.
314. Gillman, I. G., Clark, T. N., Manderville, R. A., Oxidation of ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage, Chem. Res. Toxicol. 1999, 12, 1066-1076.
315. Mally, A., Zepnik, H., Wanek, P., Eder, E. et al., Ochratoxin A: Lack of formation of covalent DNA adducts, Chem. Res. Toxicol. 2004, 17, 234-242.
316. Waidyanatha, S., Lin, P.-H., Rappaport, S. M., Characterization of chlorinated adducts of hemoglobin and albumin following administration of pentachlorophenol to rats, Chem. Res. Toxicol. 1996, 9, 647-653.
317. Ueno, Y., Biotransformation of mycotoxins in the reconstituted cytochrome P-450 system, Proc. Jpn. Assoc. Mycotoxicol. 1977, 22, 28-30.
318. Grosse, Y., Monje, M. C., Macé, K., Pfeifer, A., Pfohl-Leszkowicz, A., Use of bronchial epithelial cells expressing human cytochrome p450 for study on metabolism and genotoxicity of ochratoxin A, In Vitro Toxicol. 1997, 10, 93-102.
319. Omar, R. F., Gelboin, H. V., Rahimtula, A. D., Effect of cytochrome P450 Induction on the metabolism and toxicity of ochratoxin A, Biochem. Pharmacol. 1996, 51, 207-216.
320. Guengerich, F. P., Characterization of human cytochrome P450 enzymes, FASEB J. 1992, 6, 745-748.
321. Simarro Doorten, A. Y., Bull, J., van der Doelen, M. A. M., Fink-Gremmels, J., Metabolism-mediated cytotoxicity of ochratoxin A, Toxicol. In Vitro 2004, 18, 271-277.
322. De Groene, E. M., Hassing, I. G. A. M., Blom, M. J., Seinen, W. et al., Development of human cytochrome P450-expressing cell lines: Application in mutagenicity testing of ochratoxin A, Cancer Res. 1996, 56, 299-304.
323. Zepnick, H., Pahler, A., Schauer, U., Dekant, W., Ochratoxin A-induced tumors formation: Is there a role of reactive OTA metabolites?, Toxicol. Sci. 2001, 59, 59-67.
324. Gustafsson, J. A., Mode, A., Norstedt, G., Skett, P., Sex steroid induced changes in hepatic enzymes, Annu. Rev. Physiol. 1983, 45, 51-60.
325. Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T., Kato, R., Sex difference of cytochrome P-450 in the rat: Purification, characterization, and quantitation of constitutive forms of cytochrome-P450 from liver microsomes of male and female rats, Arch. Biochem. Biophys. 1983, 225, 758-770.
326. Kamataki, T., Shimada, M., Maeda, K., Kato, R., Pituitary regulation of sex-specific forms of cytochromeP-450 in liver microsomes of rats, Biochem. Biophys. Res. Commun. 1985, 130, 1247-1253.
327. Rendic, B., Di Carlo, F. J., Human cytochrome P450 enzymes: A status report summarizing their reactions, inducers, and inhibitors, Drug Met. Rev. 1997, 29, 413.
328. Eling, T. E., Thompson, D. C., Fouremen, G. L., Curtis, J. F., Hughes, M. F., Prostaglandin H synthase and xenobiotic oxidation, Annu. Rev. Pharmacol. Toxicol. 1999, 30, 1-45.
329. Yamamoto, S., Mammalian lipoxygenases: Molecular structures and functions, Biochim. Biophys. Acta 1992, 1128, 117-131.
330. Rahimtula, A. D., Bereziat, J. C., Bussacchini-Griot, V., Bartsch, H., Lipid peroxydation as a possible cause of ochratoxin toxicity, Biochem. Pharmacol. 1988, 37, 4469-4477.
331. Omar, R. F., Hasinoff, B. B., Mejilla, F., Rahimtula, A. D., Mechanism of ochratoxin A stimulated lipid peroxidation, Biochem. Pharmacol. 1990, 40, 1183-1191.
332. Capdevila, J. H., Falck, J. R., Estabrook, R. W., Cytochrome P450 and the arachidonate cascade, FASEB J. 1992, 6, 731-736.
333. Shinjo, F., Yoshimoto, T., Yokoyama, C., Yamamoto, S. et al., Studies on porcine arachidonate 12-lipoxygenase using its monoclonal antibodies, J. Biol. Chem. 1986, 261, 3371.
334. Hunter, J. A., Finkbeiner, W. E., Nadel, J. A., Goetzl, E. J., Holtzman, M. J., Predominant generation of 5-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea, Proc. Nat. Acad. Sci. USA 1985, 82, 4633.
335. Henke, D., Danilowicz, R. M., Curtis, J. F., Boucher, R. C., Eling, T. E., Metabolism of arachidonic acids by human nasal and bronchial epithelia cells, Arch. Biochem. Biophys. 1988, 268, 426-431.
336. Goetzl, E. J., Songzhu, A., Smith, W., Specificity of expression and effects of ecosanoid mediators in normal physiology and human diseases, FASEB J. 1995, 9, 1051-1058.
337. Oliw, E. H., Biosynthesis of 18 (RD)-hydroeicosatetraenoic acid from arachidonic acid by microsomes of monkey seminal vesicles. Some properties of a novel fatty acid omega 3-hydroxylase and omega 3-epoxygenase, J. Biol. Chem. 1989, 264, 17845.
338. Mc Giff, J. C., Cytochrome P6450 metabolism of Arachidonic acid, Annu. Rev. Toxicol. 1991, 31, 339-365.
339. Roy, P., Sajan, M. P., Kulkarni, A. P., Lipoxygenase-mediated glutathione oxidation and superoxide generation, J. Biochem. Toxicol. 1995, 10, 111-120.
340. Xiao, H., Madhyastha, S., Marquardt, R. R., Li, S. et al., Toxicity of Ochratoxin A, its opened lactone forms and several of its analogs: Structure-activity relationship, Toxicol. Appl. Pharm. 1996, 137, 182-192.
341. Xiao, H., Marquardt, R. R., Abramson, D., Frohlich, A., Metabolites of ochratoxins in rat urine and in a culture of Aspergillus ochraceus, Appl. Environ. Microbiol. 1996, 62, 648-655.
342. Hoehler, D., Marquadt, R. R., McIntosh, A. R., Hatch, G. M., Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs, Biochim. Biophys. Acta 1997, 1357, 225-233.
343. Hoehler, D., Marquardt, R. R., Frohlich, A., Lipid peroxidation as one mode of action in ochratoxin A toxicity in rats and chicks, Can. J. Anim. Sci. 1997, 77, 287-292.
344. Smith, W. L., Marnett, L. J., DeWitt, D. L., Prostaglandin and thromboxane synthesis, Pharmacol. Ther. 1991, 49, 153-179.
345. 1 by lipooxygenase, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues, Carcinogenesis 1992, 13, 533-539.
346. Munday, R., Bioactivation of thiols by one-electron oxidation, Adv. Pharmacol. 1994, 27, 237-270.
347. Faucet-Marquis, V., Pont, F., Størmer, F., Rizk, T. et al., Evidence of a new dechlorinated OTA derivative formed in opossum kidney cell cultures after pre-treatment by modulators of glutathione pathways. Correlation with DNA adducts formation, Mol. Nutr. Food Res. 2006, 50, 531-542.
348. Faucet-Marquis, V., Identification des metabolites de l'ochratoxine A responsables des effets cancérogènes et des adduits à l'ADN, Ph.D. Thesis, Institut National Polytechnique de Toulouse, France 2005.
349. Castegnaro, M., Bartsch, H., Béréziat, J. C., Arvela, P. et al., Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine, Xenobiotica 1989, 19, 225-230.
350. Gautier, J.-C., Holzhaeuser, D., Markovic, J., Gremaud, E. et al., Oxidative damage and stress response from ochratoxin A exposure in rats, Free Radic. Biol. Med. 2001, 30, 1089-1098.
351. Zepnick, H., Volkel, W., Dekant, W., Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration, Toxicol. Appl. Pharmacol. 2003, 192, 36-44.
352. Pfohl-Leszkowicz, A., Castegnaro, M., Reply to letter to editor from Dekant on analysis of breakfast cereal, Food Chem. 2006, 99, 178-181.
353. Scott, P., Biomarkers of human exposure to ochratoxin A, Food Addit. Contam. 2005, Suppl. 1, 99-107.
354. Würgler, F. E., Friederich, U., Schlatter, J., Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestin in Salmonella typhimurium TA102, Mutat. Res. 1991, 261, 209-216.
355. Ueno, Y., Kubota, K., DNA-attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of Bacillus subtilis, Cancer Res. 1976, 36, 445-445.
356. Kuczuk, M. H., Benson, P. M., Health, H., Hayes, W., Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae, Mutat. Res. 1978, 53, 11-20.
357. Krogh, P. (Ed.), Ochratoxin A in Food, Academic Press, New York 1987, pp. 97-121.
358. Umeda, M., Tsutsui, T., Saito, M., Mutagenicity and inducibility of DNA single strand breaks and chromosome aberrations by various mycotoxins, Gann 1977, 68, 619-625.
359. Hennig, A., Fink-Gremmels, J., Leistner, L., Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 255-260.
360. Obrecht-Plumio, S., Chassat, T., Dirheimer, G., Marzin, D., Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes, Mutat. Res. 1999, 446, 95-102.
361. Mori, H., Kawai, K., Bayashi, F., Kuniyasu, T. et al., Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes, Cancer Res. 1984, 44, 2918-2923.
362. Dörrenhaus, A., Föllmann, W., Effect of Ochratoxin A on DNA repair in cultures of rat hepatocytes and porcine urinary bladder kidney epithelial cells, Arch. Toxicol. 1997, 71, 709-713.
363. Dörrenhaus, A., Flieger, A., Golke, K., Schulze, H. et al., Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin ochratoxin A, Toxicol. Science 2000, 53, 271-277.
364. Lebrun, S., Föllmann, W., Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet essay), Arch. Toxicol. 2002, 75, 734-741.
365. Auffray, Y., Boutibonnes, P., Evaluation of the genotoxic activity of some mycotoxins using E. coli, in the SOS spot test, Mutat. Res. 1986, 171, 79-82.
366. Malaveille, C., Brun, G., Bartsch, H., Genotoxicity of ochratoxin A and structurally related compounds in E. coli strains, studies on their mode of actions, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 261-266.
367. Vogel, E. W., Nivard, M. J. M., Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination, Mutagenesis 1993, 8, 57-81.
368. Föllmann, W., Hillebrand, I. E., Creppy, E. E., Bold, H. M., Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated by OTA and alpha OTA, Arch. Toxicol. 1995, 69, 280-286.
369. Lioi, M. B., Santoro, A., Barbieri, R., Salzano, S., Ursini, M. V., Ochratoxin A and zearalenone: Acomparative study on genotoxic effects and cell death induced in bovine lymphocytes, Mutat. Res. 2004, 557, 19-27.
370. Degen, G. H., Gerber, M. M., Obrecht, S., Pfohl-Leszkowicz, A., Dirheimer, G., Genotoxicity and cytotoxicity of ochratoxin A in ovine seminal vesicle cell cultures, Arch. Pharmacol. 1994, 349, 121 (Abstract).
371. Degen, G. H., Gerber, M. M., Obrecht-Pflumio, S., Dirheimer, G., Induction of micronuclei with ochratoxin A in ovine seminal vesicle cells, Arch. Toxicol. 1997, 71, 365-371.
372. Dopp, E., Müller, J., Hahnel, C., Schiffmann, D., Induction of genotoxic effects and modulation of the intracellular calcium level in Syrian hamster embryo (SHE) Fibroblasts caused by ochratoxin A, Food Chem. Toxicol. 1999, 37, 713-721.
373. Ehrlich, V., Darroudi, F., Uhl, M., Steinkellner, H. et al., Genotoxic effects of ochratoxin A in human derived hepatoma HepG2 cells, Food Chem. Toxicol. 2002, 40, 1085-1090.
374. Robbiano, L., Baroni, D., Carrozzino, R., Mereto, E., Brambilla, G., DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney, Toxicology 2004, 204, 187-195.
375. Creppy, E. E., Kane, A., Dirheimer, G., Lafarge-Frayssinet, C. et al., Genotoxicity of ochratoxin A in mice, DNA single-strand break evaluation in spleen, liver and kidney, Toxicol. Lett. 1985, 28, 29-35.
376. Manolova, Y., Manolov, G., Parvanova, L., Petkova-Bocharova, T. et al., Induction of characteristic chromosomal aberrations, particularly x-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy, Mutat. Res. 1990, 231, 143-149.
377. Manolov, G., Manolova, Y., Castegnaro, M., Chernozemsky, I. N., Chromosomal alterations in lymphocytes of patients with Balkan endemic nephropathy and of healthy individuals after incubation in vitro with ochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 267-272.
378. Malaveille, C., Brun, G., Bartsch, H., Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites, Mutat. Res. 1994, 307, 141-147.
379. Xiao, H., Marquadt, R. R., Frohlich, A., Ling, Y. Z., Synthesis and structural elucidation of analogs of ochratoxin A, J. Agric. Food Chem. 1995, 43, 524-530.
380. Lebrun, S., Golka, K., Schulze, H., Follmann, W., Glutathione-S- transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells, Toxicology 2006, 224, 81-90.
381. Miller, J. A., Miller, E. C., Some current perspectives on chemical carcinogenesis in humans and experimental animals, Cancer Res. 1981, 38, 1476.
382. Lutz, W., Gaylor, D., Significance of DNA adducts at low dose: Shortening the time to spontaneous tumor occurrence, Regul. Toxicol. Pharmacol. 1996, 25, 29-34.
383. Pfohl-Leszkowicz, A., Chakor, K. Creppy, E. E., Dirheimer, G., DNA-adduct formation in mice treated with ochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Scientific Publications No. 115, Lyon, France 1991, pp. 245-253.
384. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., Dirheimer, G., Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A, Mutat. Res. 1993, 289, 265-273.
385. Pfohl-Leszkowicz, A., Grosse, Y., Castegnaro, M., Petkova-Bocharova, T. et al., Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects, IARC Sci. Publ. 1993, 124, 141-148.
386. Petkova-Bocharova, T., Stoichev, I. T., Chernozemsky, I. N., Pfohl-Leszkowicz, A., Formation of DNA adducts in tissues of mice progeny through transplacental contamination after administration of a single dose of ochratoxin A to the pregnant mother, Environ. Mol. Mutagen. 1998, 32, 155-162.
387. Miljkovic, A., Pfohl-Leszkowicz, A., Dobrota, M., Mantle, P. G., Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats, Exp. Toxicol. Pathol. 2002, 54, 305-312.
388. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Gharbi, A. et al., Is the oxydative pathway implicated in the genotoxicity of ochratoxin A? in: Creppy, E. E., Castegnaro, M., Dirheimer, G. (Eds.), Human Ochratoxicosis and its Pathologies, John Libbey Eurotext, colloque INSERM 1993, Vol. 231, pp. 177-187.
389. Grosse, Y., Castegnaro, M., Macé, K., Bartsch, H. et al., Evaluation of ochratoxin A genotoxicity by DNA-adducts detection: Cytochromes P450 implicated, Clin. Chem. 1995, 12, 1927-1929.
390. Pfohl-Leszkowicz, A., Obrecht, S., Grosse, Y., Dirheimer, G., Involvement of antioxidants and inhibitors of glutathione conjugation in ochratoxin A genotoxicity in mice liver and kidney, Toxicol. Lett. 1994, 74, 64 (Abstract).
391. Gautier, J., Richoz, J., Welti, D. H., Markovic, J. et al., Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes, Chem. Res. Toxicol. 2000, 14, 34-45.
392. Obrecht-Pflumio, S., Grosse, Y., Pfohl-Leszkowicz, A., Dirheimer, G., Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney, Arch. Toxicol. 1996, 70, 244-248.
393. Grosse, Y., Chekir-Ghedira, L., Huc, A., Obrecht-Pflumio, S. et al., Retinol, ascorbic acid and alpha tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone, Cancer Lett. 1997, 114, 225-229.
394. Kamp, H. G., Eisenbrand, G., Janzowski, C., Kiossev, J. et al., Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats, Mol. Nutr. Food Res. 2005, 49, 1160-1167.
395. Azémar B., Etude du rôle de l'ochratoxine A, une mycotoxine alimentaire dans l'induction des cancers des voies urinaires chez l'Homme. Mécanisme moléculaire impliqués, Ph.D. Thesis, Institut National Polytechnique de Toulouse, France 2000.
396. Wang, M., Nishikawa, A., Chung, F. L., Differential effects of thiols on modifications via alkylation and Michael addition by alpha-acetoxy-N- nitrosopyrrolidine, Chem. Res. Toxicol. 1992, 5, 528-531.
397. Umemura, T., Hasegawa, R., Sai-Kato, K., Nishikawa, A. et al., Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotricetate, Jpn. J. Cancer Res. 1996, 87, 882-886.
398. Gartland, K. P. R., Eason, C. T., Bonner, F. W., Nicholson, J. K., Effects of biliary cannulation and buthionine sulphoximine pretreatment on the nephrotoxicity of para-aminophenol in the Fischer 334 rat, Arch. Toxicol. 1990, 64, 14-25.
399. Lash, L. H., Andrews, M. W., Cytotoxicity of S-(1,2-dichlorovinyl) glutathione and S-(1,2dichlorovinyl)-L-cysteine in isolated rat kidney cells, J. Biol. Chem. 1986, 261, 13076-13081.
400. Schaaf, G. J., Nijmeijer, S. M., Maas, R. F. M., Roestenberg, P. et al., The role of oxidative stress in the ochratoxin A mediated toxicity in proximal tubular cells, Biochim. Biophys. Acta 2002, 1588, 149-158.
401. Azémar, B., Pinelli, E., Escourrou, G., Plante, P., Pfohl-Leszkowicz, A., Evidence that DNA adducts in some human kidney tumours in France are related to ochratoxin A, Mutat. Res. 1997, 379, S157 (Abstract).
402. Azémar, B., Pinelli, E., Plante, P., Escourron, G. et al., Some human kidney tumours in France exhibited a specific ochratoxin A-DNA adduct pattern, Rev. Med. Vet. 1998, 149, 653 (Abstract).
403. Calcutt, M. W., Gillman, I. G., Noftle, R. E., Manderville, R. A., Electrochemical oxidation of ochratoxin A: Correlation with 4-chlorophenol, Chem Res. Toxicol. 2001, 14, 1266-1272.
404. Dai, J., Park, G., Wright, M. W., Adams, M. et al., Detection und characterization of glutathione conjugate of ochratoxin A, Chem. Res. Toxicol. 2002, 15, 1581-1588.
405. Arif, J. M., Lehmler, H. J., Robertson, W., Gupta, R. C., Interaction of benzoquinone- and hydroquinone derivatives of lower chlorinated biphenyls with DNA and nucleotides in vitro, Chem. Biol. Interact. 2003, 142, 307-316.
406. Lin, P. H., La, D. K., Upton, P. B., Swenberg, J. A., Analysis of DNA adducts in rats exposed to pentachlorophenol, Carcinogenesis 2002, 23, 365-369.
407. Dai, J., Wright, M. W., Manderville, R. A., Ochratoxin A forms a carbon-bonded C8_deoxyguanosine nucleoside adduct: Implication for C8_reactivity by a phenolic radical, J. Am. Chem. Soc. 2003, 125, 3716-3717.
408. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., Manderville, R. A., Ochratoxin A forms a carbon-bonded C8_deoxyguanosine nucleoside adduct: Implication for C8_reactivity by a phenolic radical, Chem. Res. Toxicol. 2004, 17, 1289-1296.
409. Obrecht-Pflumio, S., Dirheimer, G., Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in the presence of ochratoxin A, Arch. Toxicol. 2001, 75, 583-590.
410. Obrecht-Pflumio, S., Dirheimer, G., In vitro DNA and dGMP adducts formation caused by ochratoxin A, Chem. Biol. Interact. 2000, 127, 29-44.
411. Tozlovanu, M., Faucet-Marquis, V., Pfohl-Leszkowicz, A., Manderville, R. A., Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction, Chem. Res. Toxicol. 2006, 19, 1241-1247.
412. Dai, J., Sloat, A. L., Wright, M. W., Manderville, R. A., Chem. Res. Toxicol. 2005, 18, 771-779.
413. Arlt, V. M., Pfohl-Leszkowicz, A., Cosyns, J. P., Schmeiser, H. H., Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy, Mutat. Res. 2001, 494, 143-150.
414. Turesky, R. J., Perspective: Ochratoxin A is not a genotoxic carcinogen, Chem. Res. Toxicol. 2005, 18, 1082-1090.
415. Phillips, D. H., Castegnaro, M., Standardization and validation of DNA adduct postlabeling methods: Report of interlaboratory trials and production of recommended protocols, Mutagenesis 1999, 14, 301-315.
416. Turesky, R. J., Vouros, P., Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo, J. Chromatogr. B 2004, 802, 155-166.
417. Esaka, Y., Inagaki, S., Goto, M., Separation procedures capable of revealing DNA adducts, J. Chromatogr. B 2003, 797, 321-329.
418. Mally, A., Decker, M., Bekteshi, M., Dekant, W., Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells, Toxicology 2006, 223, 15-25.
419. Vogelstein, B., Finzler, K. M., The multistep nature of cancer, Trends Genet. 1993, 9, 138-141.
420. Weinstein, I. B., The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment, Cancer Res. 1988, 48, 4135-4143.
421. Harris, C. C., Chemical and physical carcinogenesis: Advances and perspectives for the 1990s, Cancer Res. 1991, 51, 5023S-5044S.
422. Smith, W. L., Fitzpatrick, F. A., Prostaglandin and thromboxane synthesis, The eicosanoids: Cyclooxygenase, lipoxygenase, and epoxygenase pathways, in: Vance, D. E., Vance, J. E. (Eds.), Biochemistry of Lipids, Lipoproteins and Membranes, Elsevier, Canada 1996, pp. 283-308.
423. Shimada, T., Sugie, A., Shindo, M., Nakajima, T et al., Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene, Toxicol. Appl. Pharmacol. 2003, 187, 1-10.
424. Gustafsson, J. A., Mode, A., Norstedt, G., Skett, P., Sex steroid induced changes in hepatic enzymes, Annu. Rev. Physiol. 1983, 45, 51-60.
425. Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T., Kato, R., Sex difference of cytochrome P-450 in the rat: Purification, characterization, and quantitation of constitutive forms of cytochrome-P450 from liver microsomes of male and female rats, Arch. Biochem. Biophys. 1983, 225, 758-770.
426. Kamataki, T., Shimada, M., Maeda, K., Kato, R., Pituitary regulation of sex-specific forms of cytochrome P-450 in liver microsomes of rats, Biochem. Biophys. Res. Commun. 1985, 130, 1247-1253.
427. Cheung, Y. L., Kerr, A. C., Mc Fadyen, M. C., Melvin, W. T., Murray, G. I., Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours, Cancer Lett. 1999, 139, 199-205.
428. McFadyen, M. C., Cruickshank, M. E., Miller, I. D., Cytochrome P 450 CYP1B1 over-expression in primary and metastatic ovarian cancer, Br J. Cancer 2001, 85, 242-246.
429. Murray, G. I., Taylor, M. C., McFadyen, M. C., McKay, J. A. et al., Tumor-specific expression of cytochrome P450 CYP 1B1, Cancer Res. 1997, 57, 3026-3031.
430. Carnell, D. M., Smith, R. E., Path, M. R. C., Daley, F. M. et al., Target validation of cytochrome P450 CYP1B1 in protstate carcinoma with protein expression in associated hyperplastic and premalignant tissue, Int. J. Radiat. Oncol. Biol. Phys. 2004, 58, 500-509.
431. Prescott, S. M., Fitzpatrick, F. A., Cyclooxygenase 2 and carcinogenesis, Biochim. Biophys. Acta 2000, 1470, 69-78.
432. Williams, C. S., Mann, M., Dubois, R. N., The role of cyclooxygenase in inflammation cancer and development, Oncogene 1999, 18, 7908-7916.
433. Khan, K. N. M., Knapp, D. W., Denicola, D. B., Harris, R. K., Expression of cyclooxygenase 2 in transitional cell carcinoma of the urinary bladder in dogs, Am. J. Vet. Res. 2000, 61, 478-481.
434. Majima, M., Amano, H., Hayashi, I., Prostanoid receptor signaling relevant to tumor growth and angiogenesis, Trends Pharmacol. Sci. 2003, 24, 624-629.
435. Wang, J. L., Cheng, H. F., Shappell, S., Harris, R. C., A selective cyclooxygenase 2 inhibitor decreases proteinuria and retards progressive renal injury in rats, Kidney Int. 2000, 57, 2334-2342.
436. Zha, S., Yegnasubramanian, V., Nelson, W., Isaacs, W., De Marzo, A., Cyclooxygenases in cancer: Progress and perspectives, Cancer Lett. 2004, 215, 1-20.
437. Pruthi, R. S., Derksen, E., Gaston, K., Wallen, E. M., Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer, Urology 2004, 64, 637-642.
438. Tuna, B., Yurokoglu, K., Gurel, D., Mungan, U., Kirkali, Z., Significance of COX-2 expression in human renal cell carcinoma, Urology 2004, 64, 1116-1120.
439. Miyata, Y., Koga, S., Kanda, S., Expression of cyclooxygenase 2 in renal cell carcinoma: Correlation with tumour cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase 2 and survival, Clin. Cancer Res. 2003, 9, 1741-1749.
440. Chen, Q., Shinohara, N., Abe, T., Association between growth stimulation by phenobarbital and expression of cytochromes P450 1A1, 1A2, 2B1/2 and 3A1 in hepatic hyperplasic nodules in male F344 rats, Int. Cancer 2004, 108, 825-832.
441. Reed, G. A., Oxidation of environmental carcinogens by prostaglandins H synthase, Environ. Carcinogen. Rev. 1988, 6, 223-229.
442. Eling, T. E., Thompson, D. C., Fouremen, G. L., Curtis, J. F., Hughes, M. F., Prostaglandin H synthase and xenobiotic oxidation, Annu. Rev. Pharmacol. Toxicol. 1990, 30, 1-45.
443. Yamamoto, S., Mammalian lipoxygenases: Molecular structures and functions, Biochim. Biophys. Acta 1992, 1128, 117-131.
444. Schwartzman, M. L., Abraham, N., Caroll, M. A., Levere, R., McGiff, J. C., Regulation of arachidonic acid metabolism by cytochrome P450 in rabbit kidney, Biochem. J. 1986, 238, 283-290.
445. Schwartzman, M. L., Martasek, P., Rios, A., Levere, R. D., Solangi, K., Cytochrome P450-dependent arachidonic acid metabolism in human kidney, Kidney Int. 1990, 37, 94-99.
446. 4 formation and c-jun expression. Proceeding 2nd European Workshop 99'Molecular Toxicology, Paris, 5-8 September 1999.
447. Pfohl-Leszkowicz, A., Pinelli, E., Castegnaro, M., Overview of molecular mechanisms involved in the nephrotoxicity and carcinogenicity of ochratoxin A, Symposium Food Safety in Europe, Londres, 19th-20th October 2000.
448. Teng, D. H., Perry, W. L., Hogan, J. K., Baumgard, M. et al., Human mitogen-activated protein kinase kinase 4 as a candidate tumor supressor, Cancer Res. 1997, 57, 4177-4182.
449. Schramek, H., Wilflingseder, D., Pollack, V., Freundlinger, R. et al., Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby Canine Kidney-C7 cell dedifferentiation, J. Pharmacol. Exp. Ther. 1997, 283, 1460-1468.
450. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., et al., Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar cocnetrations, J. Pharmacol. Exp. Ther. 2000, 293, 837-844.
451. Gekle, M., Gassner, B., Freudinger, R., Mildenberger, S. et al., Characterization of an ochratoxin a -dedifferentiated and cloned renal epithelial cell line, Toxicol. Appl. Pharmacol. 1998, 152, 282-291.
452. Sauvant, C, Holzinger, H., Gekle, M., The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells, Cell Physiol. Biochem. 2005, 15, 1-4.
453. Berndt, W. O., Hayes, A. W., Bagget, J. M., Effects of fungal toxinson renal slice calcium balance, Toxicol. Appl. Pharmacol. 1984, 74, 78-85.
454. Rahimtula, A. D., Chong, X., Alterations in calcium homeostasis as possible cause of ochratoxin A nephrotoxicity, IARC. Sci. Publ. 1991, 115, 207-214.
455. Lin, L. L., Wartmann, M., Lin, A. Y., Knopf, J. L. et al., Analysis of DNA adducts in rats exposed to pentachlorophenol, Cell 1993, 72, 269-278.
456. Gekle, M., Sauvant, C., Schwerdt, G., Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells, Mol. Nutr. Food Res. 2005, 49, 118-130.
457. Sugiyama, H., Kashihara, N., Makino, H., Yamasaki, Y., Apoptosis in glomerular sclerosis, Kidney Int. 1996, 49, 103-111.
458. Thomas, S. E., Andoh, T. F., Pichler, R. H., Shankland, S. J. et al., Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis, Kidney Int. 1998, 53, 897-908.
459. Wilson, P. D., Polycystic kidney disease, N. Engl. J. Med. 2004, 350, 151-164.
460. Ortiz, A., Lorz, C., Justo, P., Catalan, M. P., Egido, J., Contribution of apoptotic cell death to renal injury, J. Cell Mol. Med. 2001, 5, 18-32.
461. Mantle, P. G., Milijkovic, A., Udupa, V., Dobrota, M., Does apoptois cause renal atrophy in Balkan endemic nephropathy?, Lancet 1998, 352, 1118-1119.
462. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S. et al., Apoptosis and oxidative stress induced by ocratoxin A in rat kidney, Arch. Toxicol. 2003, 77, 685-693.
463. Kamp, H. G., Eisenbrand, G., Janzowski, C., Kiossev, J. et al., Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats, Mol. Nutr Food Res. 2005, 49, 1160-1167.
464. Steyn, P. S., Ochratoxins and related dihydroisocoumarins, in: Betina, V. (Ed.), Mycotoxins-Production, Isolation, Separation and purification, Elsevier, Amsterdam 1984, pp. 183-216.
465. Zimmerli, B., Dick, R., Ochratoxin A in table wine and grape juice: Occurnece and risk assessment, Food Add. Cont. 1996, 13, 655-668.
466. Fuchs, R., Hult, K., Peraica, M., Radic, B., Plestina, R., Conversion of ochratoxin C into ochratoxin A in vivo, Appl. Environ. Microbiol. 1984, 48, 41-42.
467. Wei, R. D., Still, P. E., Smalley, E. B., Schnoes, H. K., Strone, F. M., Isolation and partial characterization of a mycotoxin from Penicillium roqueforti, Appl. Env. Microbiol. 1973, 25, 111-114.
468. Müller, G., Rosner, H., Rohrmann, B., Erler, W. et al., Effect of the mycotoxin ochratoxin A and some of ist metabolites on human cell line THP-1, Toxicology 2003, 184, 69-82.
469. Müller, G., Burkert, B., Rosner, H., Köhler, H., Effects of the mycotoxin ochratoxin A and some of its metabolites on human kidney cell lines, Toxicol. In Vitro 2003, 17, 441-448.
470. Müller, G., Burkert, B., Möller, U., Diller, R. et al., Ochratoxin A and some of ist derivatives modulate radical formation of porcine blood monocytes and granulocytes, Toxicology 2004, 199, 251-259.
471. Xu, B.-J., Jia, X.-Q., Gu, L.-J., Sung, C.-K., Review on the qualitative and quantitative analysis of the mycotoxin citrinine, Food Control 2006, 17, 271-285.
472. Kogika, M. M., Hagiwara, M. K., Mirandola, R. M., Experimental citrinin nephrotoxicosis in dogs: Renal function evaluation, Vet. Hum. Toxicol. 1993, 35, 136-140.
473. Kitchen, D. N., Carlton, W. W., Hinsman, J., Ochratoxin A and citrinin induced nephrosis in beagle dogs. III Terminal renal ultrastructural alterations, Vet. Pathol. 1977, 14, 392-406.
474. Lockard, V. G., Phillips, R. D., Hayes, A. W., Berndt, W. O., O'Neal, R. M., Citrinin nephrotoxicity in rats: A light and electron microscopic study, Exp. Mol. Pathol. 1980, 32, 226-240.
475. Jordan, W. H., Carlton, W. W., Sansing, G. A., Citrinin mycotoxicosis in the rat, toxicology and pathology, Food Cosmet. Toxicol. 1978, 16, 431-439.
476. Jordan, W. H., Carlton, W. W., Sansing, G. A., Citrinin mycotoxicosis in the syrian hamster, Food Cosmet. Toxicol. 1978, 16, 335-363.
477. Phillips, R. D., Hayes, A. W., Berndt, W. O., Williams, W. L., Effects of citrinin on renal function and structure, Toxicology 1980, 16, 123-137.
478. Hanika, C., Carlton, W. W., Tuite, J., Citrinin mycotoxicosis in the rabbit, Food Chem. Toxicol. 1983, 21, 487-493.
479. Hanika, C., Carlton, W. W., Boon, G. D., Tuite, J., Citrinin mycotoxicosis in the rabbit: Clinicopathological alterations, Food Chem. Toxicol. 1984, 22, 999-1008.
480. Hanika, C., Carlton, W. W., Hinsman, E. J., Tuite, J., Citrinin mycotoxicosis in the rabbit: Ultrastructural alterations, Vet. Pathol. 1986, 23, 145-253.
481. Brown, T. P., Manning, R. O., Fletcher, O. J., Wyatt, R. D., Avian Dis. 1986, 30, 191-198.
482. Mehdi, N. A., Carlton, W. W., Boon, G. D., Tuite, J., Studies on the sequential development and pathogenesis of citrinin mycotoxicosis in turkeys and ducklings, Vet. Pathol. 1984, 21, 216-223.
483. Friis, P., Hasselager, E., Krogh, P., Isolation of citrinin and oxalic acid from Penicillium viridicatum and their neprotoxicity in rats and pigs, Acta Pathol. Microbiol. Scand. 1969, 77, 559-560.
484. Cole, R. J., Cox, R. H., Handbook of Fungal Metabolites. Academic press, New York, London, Toronto, Sydney, San Francisco 1981.
485. Sansing, G. A., Lillehoj, E. B., Detroy, R. W., Miller, M. A., Synergistic toxic effects of citirnin, ochratoxin A and penicillic acid in mice, Toxicology 1976, 14, 213-220.
486. Thacker, H. L., Carlton, W. W., Citrinin mycotoxicosis in the guinea pig, Food Cosmet. Toxicol. 1977, 15, 553-556.
487. Siraj, M., Phillips, T. D., Hayes, A. W., Effects of the mycotoxins citrinin and ochratoxin A on hepatic mixed-function oxidase and adenosine triphosphatase in neonatal rats, J. Toxicol. Environ. Health 1981, 8, 131-140.
488. Shinohara, D. K., Arai, M., Hirao, K., Sugihara, S. et al., Combination effect of citrinin and other chemicals on rat kidney tumorigenesis, Gann 1976, 67, 147-155.
489. Arai, M., Hibino, T., Tumorigenicity of citrinin in male F344 rats, Cancer Lett. 1983, 17, 281-287.
490. Jeswal, P., Citrinin induced chromosomal abnormalities in the bone marrow cells of mus musculus, Cytobios 1986, 86, 329-331.
491. Thust, R., Kneist, S., Activity of citrinin metabolised by rat and human microsome fractions in clastogenicity and SCE assay on Chinese hamster V79E cells, Mutat. Res. 1979, 67, 321-330.
492. Bernhoft, A., Keblys, M., Morrison, E., Larsen, H. G. S., Flåøyen, A., Combined effects of selected Penicillium mycotoxins on in vitro proliferation of porcine lymphocytes, Mycopathologia 2004, 158, 441-450.
493. Heussner, A. H., Dietrich, D. R., O'Brien, E., In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells, Toxicol. In Vitro 2006, 20, 332-341.
494. Knasmüller, S., Cavin, C., Chakraborty, A., Darroudi, F. et al., Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: Implications for risk assessment, Nutr. Cancer 2004, 50, 190-197.
495. Creppy, E. E., Lorkowski, G., Beck, G., Roschenthaler, R., Dirheimer, G., Combined action of citrinin and ochratoxin A on hepatoma tissue culture cells, Toxicol. Lett. 1980, 5, 375-380.
496. Berndt, W. O., Hayes, A. W., In vivo and in vitro changes in renal function caused by ochratoxin A in the rat, Toxicology 1979, 12, 5-17.
497. Glahn, R. P., Wideman, R. F. J., Evangelisti, J. W., Huff, W. E., Effects of ochratoxin A alone and in combination with citrinine on kidney function. Of single comb white leghorn, Poult. Sci. 1988, 67, 1034-1042.
498. Vesela, D., Vesely, D., Jelinek, R., Toxic effects of ochratoxin A and citrinin, alone and in combination, on chicken embryos, Appl. Environ. Microbiol. 1983, 45, 91-93.
499. Huff, W. E., Kubena, L. F., Harvey, R. B., Doerr, J. A., Mycotoxin interactions in poultry and swine, J. Anim. Sci. 1981, 66, 2351-2355.
500. Thacker, H. L., Carlton, W. W., Sansing, G., A toxicity of citrinin and ochratoxin A in guinea pigs, Toxicol. Appl. Pharmacol. 1975, 33, 155-160.
501. Braunberg, R. C., Barton, C. N., Gantt, O. O., Friedman, L., Interaction of citrinin and ochratoxin A, Nat. Toxins 1994, 2, 124-131.
502. Molinié, A., Pfohl-Leszkowicz, A., Toxic effects of cocontamination of ochratoxin A and citrinine, Drug Metab. Rev. 2003, 35, 77.
503. Tozlovanu, M., Faucet-Marquis, V., Molinié, A., Castegnaro, M. et al., Combined toxic effects of ochratoxin A and citrinin, in vitro and in vivo, Proceeding of the ACS Meeting, San Francisco, September 2006.
504. Tozlovanu, M., Faucet-Marquis, V., Molinié, A., Castegnaro, M. et al., Citrinin enhances the toxic and Genotoxic effects of ochratoxin A in vitro and in vivo, Coll. Antropol. 2006, 30, 18.